Skip to main content
Year archive

aap Implantate AG — 2023 filings

All 51 regulatory filings released by aap Implantate AG (AAQ1) in 2023, sourced directly from the official regulator.

51 Filings
2023 Period
2023 filings (51)
Filing Released Lang
Adjustment of the forecast for revenue and EBITDA for FY 2023; implementation of a personnel measure to achieve positive EBITDA and balanced cash flow in the operating trauma business
Regulatory Filings
2023-12-21 English
Visible acceleration in clinical trial with already more than 60 patients; increase in funding of around EUR 0.4 million underscores innovative strength of silver coating technology
Regulatory Filings
2023-10-30 English
aap Implantate AG: Deepblue Holding AG, Subscription of partial bonds in the context of the private placement for a convertible bond
Director's Dealing
2023-10-06 English
aap Implantate AG: Deepblue Holding AG, Exercise of subscription rights in the context of a subscription offer for a convertible bond
Director's Dealing
2023-10-05 English
aap places mandatory convertible bond 2023/2028 in the amount of EUR 2.5 million
Capital/Financing Update
2023-10-04 English
aap Implantate AG: Marek Hahn, Granting of 47,364 subscription rights as part of a subscription offer for a convertible bond
Director's Dealing
2023-09-19 English
aap offers its shareholders a EUR 2.7 million mandatory convertible bond; subscription commitments of around 83% already received; accompanying restructuring measures in preparation
Share Issue/Capital Change
2023-09-08 English
Hiring of Jochen Rahner as Director Finance, IR and IT to succeed CFO Marek Hahn
Board/Management Information
2023-08-31 English
Q2/2023: Revenue growth in all regions (+8 %) and adjusted earnings improvement (EBITDA +21 %)
Earnings Release H1 2023
2023-08-14 English
Halbjahresfinanzbericht nach WpHG für den Zeitraum vom 01.01.2023 bis zum 30.06.2023
Interim / Quarterly Report H1 2023
2023-08-14 German
Halbjahresabschluss 2023
Interim / Quarterly Report H1 2023
2023-08-14 German
Report Publication Announcement 2023
Report Publication Announcement
2023-08-10 English
Hinweis auf Halbjahresfinanzbericht vom 01.01.2023 bis zum 30.06.2023
Report Publication Announcement
2023-08-10 German
Results of aap Implantate AG's Annual General Meeting underpin support for corporate strategy pursued
AGM Information
2023-07-27 English
No resolution on certain capital measures at the Annual General Meeting
AGM Information
2023-07-21 English
Accelerated patient recruitment; adapted study protocol meets expectations for human clinical trial of breakthrough silver antibacterial coating technology
Regulatory Filings
2023-07-20 English
US and LATAM businesses continue with double-digit growth; Q2 sales increase of +8%; solid growth of +6% in H1/2023
Earnings Release H1 2023
2023-07-18 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2023-06-30 English
aap Implantate AG: Bekanntmachung der Einberufung zur Hauptversammlung am 25.07.2023 in Berlin mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2023-06-16 German
aap Implantate AG: Rubino di Girolamo, buy
Director's Dealing
2023-06-15 English
Proposed capital measures in connection with the convening of the Annual General Meeting: Maintaining freedom of action in a macroeconomic environment characterized by high uncertainties
Share Issue/Capital Change
2023-06-14 English
Executive Board proposes in the invitation to the Annual General Meeting various capital measures for resolution
AGM Information
2023-06-13 English
aap CFO Marek Hahn ends his Management Board activities at the end of the year; contracts of CEO and COO extended until the end of 2025
Board/Management Information
2023-05-25 English
Q1/2023: Solid start with slight sales growth (+3 %) and unchanged EBITDA; US and LATAM business grow well into double digits
Earnings Release Q1 2023
2023-05-15 English
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements
2023-05-03 English
Consolidation in FY/2022: Small decline in sales with stable cost base and strong improvement in operating cash flow (+23 %) in challenging environment
Earnings Release FY 2022
2023-04-28 English
Jahresfinanzbericht 2022
Annual Report FY 2022
2023-04-28 German
Report Publication Announcement 2023
Report Publication Announcement
2023-04-25 English
Hinweis auf Jahresfinanzbericht vom 01.01.2022 bis zum 31.12.2022
Report Publication Announcement
2023-04-25 German
Hinweis auf Konzernabschluss vom 01.01.2022 bis zum 31.12.2022
Report Publication Announcement
2023-04-25 German
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements
2023-04-14 English
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements
2023-04-06 English
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements
2023-04-05 English
aap Implants Inc. awarded agreement with Premier, Inc. for Small Joint Implants Upper Extremities, Small Joint Implants Lower Extremities, Podiatry Products and Accessories
Regulatory Filings
2023-04-03 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2023-03-31 English
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements
2023-03-30 English
aap Implantate AG: Marek Hahn, Subscription of shares as part of the private placement in connection with a rights issue capital increase
Director's Dealing
2023-03-30 English
aap Implantate AG: Rubino di Girolamo, Subscription of shares as part of the private placement in connection with a rights issue capital increase
Director's Dealing
2023-03-30 English
aap Implantate AG: Deepblue Holding AG, Subscription of shares as part of the private placement in connection with a rights issue capital increase
Director's Dealing
2023-03-30 English
aap Implantate AG: Merval AG, Subscription of shares as part of the private placement in connection with a rights issue capital increase
Director's Dealing
2023-03-30 English
aap Implantate AG: Agnieszka Mierzejewska, Subscription of shares as part of the private placement in connection with a rights issue capital increase
Director's Dealing
2023-03-30 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2023-03-29 English
aap receives US-American clearance (FDA) for polyaxial LOQTEQ VA Elbow system; launch planned for Q4 2023
Regulatory Filings
2023-03-21 English
Result of the capital increase with subscription rights: capital measure fully subscribed; issue of 2.4 million new shares leads to gross issue proceeds of around EUR 3.3 million
Share Issue/Capital Change
2023-03-15 English
aap Implantate AG: Langner Asset Management GmbH, Granting of 10,000 subscription rights within a capital increase with subsription rights
Director's Dealing
2023-03-01 English
aap Implantate AG: Deepblue Holding AG, Granting of 155,925 subscription rights within a capital increase with subsription rights
Director's Dealing
2023-03-01 English
aap Implantate AG: Jurgen Krebs, Granting of 272,495 subscription rights within a capital increase with subsription rights
Director's Dealing
2023-03-01 English
aap Implantate AG: Merval AG, Granting of 545,704 subscription rights within a capital increase with subsription rights
Director's Dealing
2023-03-01 English
aap Implantate AG: Marek Hahn, Granting of 9,564 subscription rights within a capital increase with subsription rights
Director's Dealing
2023-03-01 English
Good start in 2023 after challenging fiscal year 2022
Earnings Release FY 2022
2023-02-21 English
aap Implantate AG resolves on capital increase with subscription rights to strengthen its financial base
Capital/Financing Update
2023-02-21 English